SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 18.75
-0.50 (-2.60%)
May 28, 2025, 4:01 PM GMT+1
SkinBioTherapeutics Revenue
SkinBioTherapeutics had revenue of 1.58M GBP in the half year ending December 31, 2024, with 1,947.84% growth. This brings the company's revenue in the last twelve months to 2.68M, up 1,557.07% year-over-year. In the fiscal year ending June 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M with 815.26% growth.
Revenue (ttm)
2.68M
Revenue Growth
+1,557.07%
P/S Ratio
16.74
Revenue / Employee
178.57K
Employees
15
Market Cap
44.85M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |